Regency Centers (REG)
NASDAQReal EstateReit - RetailSnapshot 2026-10-29
$74.59-0.52%
Close 2026-10-30 · 1-day change
NASDAQReal EstateReit - RetailSnapshot 2026-10-29
Research Workspace
Put REG beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Retail REITs is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Reaffirm 2026 earnings guidance at $4.83-$4.87 per share: Comparison needs review.
View ThesisRevenue is growing steadily — about 8% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look high — the market is pricing in about 18% growth a year, above the roughly 7% analysts expect, leaving little room for error.
View ValuationRelatively steady — typically moves about 0% a day.
View RiskREG’s case rests on steady financial performance, though recent revenue growth is modest. The latest recorded revenue grew 4.4% year over year, and Q1 earnings beat. REG trades at 13× P/FFO versus the 11× peer median. The market is pricing in more growth than our forecast. The specific risk is pressure on liquidity and the balance sheet from preferred-share concerns. The guidance comparison needs review, so it does not confirm a break. Peer multiples imply a price about 18% below where it trades; the thesis is on watch, and this read is provisional.
Trailing returns as of 2026-10-30. REG is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 20 analysts currently covering REG (as of Oct 2026).
Based on 10 Wall Street analysts offering 12-month price targets for REG in the last 4 months.
Continue this research
Compare REG with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| REG Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Retail REITs — fair value, gap to price, and forward P/E.
Compare the value case
Put REG next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Maintain strong balance sheet and liquidity
Downgrade of preferred shares may impact liquidity and balance sheet.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $74.59
The last 12 months of price, then the range of analyst 12-month targets from today’s $74.59.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Provide initial 2026 guidance
Provides clarity on future growth expectations.
Threatens: Raise 2025 Nareit FFO guidance
Missed estimates could impact future guidance.